Rectal angiosarcoma after adjuvant chemoradiotherapy for adenocarcinoma of the rectum.
Tardío
Juan C
JC
Department of Pathology, Hospital Universitario de Fuenlabrada, Madrid, Spain.
Nájera
Laura
L
Alemany
Isabel
I
Martín
Teresa
T
Castaño
Angel
A
Pérez-Regadera
José F
JF
D000230:Adenocarcinoma / Q000628:therapy*; D000964:Antimetabolites, Antineoplastic / Q000008:administration & dosage; D017024:Chemotherapy, Adjuvant; D017809:Fatal Outcome; D005472:Fluorouracil / Q000008:administration & dosage; D006394:Hemangiosarcoma / Q000209:etiology / Q000473:pathology* / Q000601:surgery; D006801:Humans; D008297:Male; D008875:Middle Aged; D009361:Neoplasm Invasiveness; D009364:Neoplasm Recurrence, Local / Q000601:surgery; D009381:Neoplasms, Radiation-Induced / Q000473:pathology* / Q000601:surgery; D016609:Neoplasms, Second Primary / Q000473:pathology* / Q000601:surgery; D018714:Radiotherapy, Adjuvant / Q000009:adverse effects*; D012004:Rectal Neoplasms / Q000209:etiology / Q000473:pathology* / Q000601:surgery / Q000628:therapy*
D000964:Antimetabolites, Antineoplastic; D005472:Fluorouracil